Evidence map›Paper›PMID 35054927›Full record

ArticleInternational journal of molecular sciences2022

HIF2α Upregulates the Migration Factor ODZ1 under Hypoxia in Glioblastoma Stem Cells.

María Carcelén, Carlos Velásquez, Veronica Vidal, Olga Gutierrez, Jose L Fernandez-Luna

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of molecular sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.7field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Von Hippel-Lindau/Hypoxia Inducible Factor Axis in Glioblastoma.International journal of molecular sciences · 2025
    Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

María CarcelénGenetics Unit, Hospital Universitario Marqués de Valdecilla, 39008 Santander, Spain.
Carlos VelásquezInstituto de Investigación Marqués de Valdecilla (IDIVAL), 39008 Santander, Spain.ORCID 0000-0002-4443-5888
Veronica VidalGenetics Unit, Hospital Universitario Marqués de Valdecilla, 39008 Santander, Spain.
Olga GutierrezGenetics Unit, Hospital Universitario Marqués de Valdecilla, 39008 Santander, Spain.
Jose L Fernandez-LunaGenetics Unit, Hospital Universitario Marqués de Valdecilla, 39008 Santander, Spain.
Marqués de Valdecilla University Hospital · ESUniversidad de Cantabria · ES

Funding

Instituto de Investigación Marqués de Valdecilla APG/03Instituto de Salud Carlos III PI17/01399
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Gene Expression Regulation, NeoplasticBasic Helix-Loop-Helix ProteinsCell HypoxiaCell Line, TumorEndothelial PAS Domain-Containing Protein 1Gene Knockdown TechniquesGlioblastomaHumansNeoplastic Stem CellsNerve Tissue ProteinsRNA, MessengerTenascinBasic Helix-Loop-Helix ProteinsEndothelial PAS Domain-Containing Protein 1Nerve Tissue ProteinsRNA, MessengerTenascinteneurin-1glioblastomaglioblastoma stem cellsHIF2αhypoxiamigrationODZ1

Identifiers

PMID35054927
PMCPMC8775595
OpenAlexW4206678312

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.